These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 18322766)

  • 1. [Generic drugs: quality, efficacy, safety and interchangeability].
    Tschabitscher D; Platzer P; Baumgärtel C; Müllner M
    Wien Klin Wochenschr; 2008; 120(3-4):63-9. PubMed ID: 18322766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generics and cost-effective prescribing in Belgium: does bioequivalence always translate in therapeutic equivalence?
    Dupont AG; Heller F
    Acta Clin Belg; 2009; 64(5):406-14. PubMed ID: 19999388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioequivalence between innovator and generic tacrolimus in liver and kidney transplant recipients: A randomized, crossover clinical trial.
    Alloway RR; Vinks AA; Fukuda T; Mizuno T; King EC; Zou Y; Jiang W; Woodle ES; Tremblay S; Klawitter J; Klawitter J; Christians U
    PLoS Med; 2017 Nov; 14(11):e1002428. PubMed ID: 29135993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential concerns about generic substitution: bioequivalence versus therapeutic equivalence of different amlodipine salt forms.
    Meredith PA
    Curr Med Res Opin; 2009 Sep; 25(9):2179-89. PubMed ID: 19601710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug Administration.
    Davit BM; Nwakama PE; Buehler GJ; Conner DP; Haidar SH; Patel DT; Yang Y; Yu LX; Woodcock J
    Ann Pharmacother; 2009 Oct; 43(10):1583-97. PubMed ID: 19776300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brand and generic medications: are they interchangeable?
    Al-Jazairi AS; Bhareth S; Eqtefan IS; Al-Suwayeh SA
    Ann Saudi Med; 2008; 28(1):33-41. PubMed ID: 18299655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generic antiepileptic drugs-Safe or harmful in patients with epilepsy?
    Holtkamp M; Theodore WH
    Epilepsia; 2018 Jul; 59(7):1273-1281. PubMed ID: 29894004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acceptability of generic versus innovator oral medicines: not only a matter of taste.
    Tuleu C; Hughes DA; Clapham D; Vallet T; Ruiz F
    Drug Discov Today; 2021 Feb; 26(2):329-343. PubMed ID: 33217597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioequivalence requirements for generic products.
    Nation RL; Sansom LN
    Pharmacol Ther; 1994; 62(1-2):41-55. PubMed ID: 7991647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Generics in Austria 2003-2008: an update].
    Müller M
    Wien Klin Wochenschr; 2008; 120(3-4):61-2. PubMed ID: 18322765
    [No Abstract]   [Full Text] [Related]  

  • 11. Modified Regulatory Pathways to Approve Generic Drugs in the US and a Systematic Review of Their Outcomes.
    Kesselheim AS; Polinski JM; Fulchino LA; Isaman DL; Gagne JJ
    Drugs; 2015 Apr; 75(6):633-50. PubMed ID: 25822610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. United States Food and Drug Administration requirements for approval of generic drug products.
    Meyer MC
    J Clin Psychiatry; 2001; 62 Suppl 5():4-9; discussion 23-4. PubMed ID: 11305846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generic immunosuppressants.
    Medeiros M; Lumini J; Stern N; Castañeda-Hernández G; Filler G
    Pediatr Nephrol; 2018 Jul; 33(7):1123-1131. PubMed ID: 28733752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The bioequivalence and therapeutic efficacy of generic versus brand-name psychoactive drugs.
    Borgheini G
    Clin Ther; 2003 Jun; 25(6):1578-92. PubMed ID: 12860486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Regulation about generics approval].
    Laguna-Goya N; Blázquez-Pérez A; Pozo-Hernández C
    Farm Hosp; 2006; 30(6):379-84. PubMed ID: 17298196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of innovator versus generic drugs in patients with epilepsy: a systematic review.
    Talati R; Scholle JM; Phung OP; Baker EL; Baker WL; Ashaye A; Kluger J; Coleman CI; White CM
    Pharmacotherapy; 2012 Apr; 32(4):314-22. PubMed ID: 22461121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring factors underlying the attitude of community pharmacists to generic substitution: a nationwide study from Poland.
    Drozdowska A; Hermanowski T
    Int J Clin Pharm; 2016 Feb; 38(1):162-70. PubMed ID: 26620450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Levothyroxine and the problem of interchangeability of drugs with narrow therapeutic index].
    Ward LS
    Arq Bras Endocrinol Metabol; 2011 Oct; 55(7):429-34. PubMed ID: 22147090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rational use of generic psychotropic drugs.
    Carbon M; Correll CU
    CNS Drugs; 2013 May; 27(5):353-65. PubMed ID: 23620145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative assessment of the switchability of generic products.
    Karalis V; Bialer M; Macheras P
    Eur J Pharm Sci; 2013 Nov; 50(3-4):476-83. PubMed ID: 23981332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.